Impact of initiation of targeted therapy on the use of psoriatic arthritis-related treatments and healthcare consumption: a cohort study of 9793 patients from the French health insurance database (SNDS).

Laura Pina VegasSiham IgguiEmilie SbidianPascal Claudepierre

Published in: RMD open (2024)

Targeted therapy initiation for PsA reduced the use of associated treatment and healthcare, with TNFi having a slightly greater effect than IL17i and IL12/23i, except for methotrexate discontinuation.

Keyphrases

health insurance
healthcare
end stage renal disease
prostate cancer
affordable care act
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
high dose
health information
social media
adverse drug
combination therapy